<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="202">
  <stage>Registered</stage>
  <submitdate>15/08/2005</submitdate>
  <approvaldate>19/08/2005</approvaldate>
  <actrnumber>ACTRN12605000175673</actrnumber>
  <trial_identification>
    <studytitle>INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTAN</studytitle>
    <scientifictitle>INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTAN</scientifictitle>
    <utrn />
    <trialacronym>VCAPS-T</trialacronym>
    <secondaryid>2004/085</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute Ischaemic Stroke </healthcondition>
    <healthcondition>Transient Ischaemic Attack</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Atorvastatin 80mg or Irbesartan 150mg for 21 days</interventions>
    <comparator>Placebo - matching empty oral capsules for 30 days</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Inflammation (measured with FDG-PET, CRP and fibrinogen)</outcome>
      <timepoint>At baseline and day 21.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Oxidative stress (F2-isoprostanes)</outcome>
      <timepoint>At baseline and day 21.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Vascular function (20-HETE excretion and forearm vascular function)</outcome>
      <timepoint>At baseline and day 21.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Effect of treatment with 21 days of atorvastatin or irbesartan on primary outcome measures.</outcome>
      <timepoint>21 days</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients presenting to facilities of the North Metropolitan Area Health Service within 10 days of acute ischaemic stroke.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Finger prick or laboratory blood sugar level &gt; 13 mmol/L at baseline; - Acute co morbid condition (such as myocardial ischaemia or sepsis); - Pre-menopausal female; - Haemorrhage seen on initial CT.Statin exclusion criteria:  - History of sensitivity to statins; - Active liver disease or unexplained elevation in transaminasesIrbesartan exclusion criteria: - Hypotension (SBP&lt; 100mmHg or DBP&lt;70mmHg); - Hypertension (&gt;220 mmHg) or clinical imperative to lower blood pressure hyperkalaemia: &gt;5.5 mmol/L; - History of sensitivity to ATRA; - Renal impairment (defined as creatinine &gt;120 umol/L); - Current treatment with an ATRA or more than one of an ACE inhibitor, non steroidal anti-inflammatory, potassium sparing diuretic, potassium salt or cyclosporin.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Concealed (Randomisation Table held by pharmacy)</concealment>
    <sequence>Computer generated random sequence stratified by prior therapy.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/05/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Western Australia</primarysponsorname>
    <primarysponsoraddress>35 Stirling Hwy CRAWLEY WA 6009</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Weatern Australia</fundingname>
      <fundingaddress>35 Stirling Hwy CRAWLEY WA 6009</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Grants</fundingname>
      <fundingaddress>35 Stirling Hwy CRAWLEY WA 6009</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Christopher Beer</name>
      <address>Level 6
Ainslie House
48 Murray St
Perth WA 6000</address>
      <phone>+61 8 92242750</phone>
      <fax>+61 8 92242063</fax>
      <email>cdbeer@graduate.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Christopher Beer</name>
      <address>Level 6
Ainslie House
48 Murray St
Perth WA 6000</address>
      <phone>+61 8 92242750</phone>
      <fax>+61 8 92242063</fax>
      <email>cdbeer@graduate.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>